{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:44:20Z","timestamp":1790394260900,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572583"],"award-info":[{"award-number":["81572583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502278"],"award-info":[{"award-number":["81502278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372848"],"award-info":[{"award-number":["81372848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10549-017-4113-z","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T11:00:13Z","timestamp":1484564413000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer"],"prefix":"10.1007","volume":"162","author":[{"given":"Ding","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"issue":"3","key":"4113_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ng.2891","volume":"46","author":"M Gerlinger","year":"2014","unstructured":"Gerlinger M, Horswell S, Larkin J, Rowan AJ, Salm MP, Varela I, Fisher R, McGranahan N, Matthews N, Santos CR, Martinez P, Phillimore B, Begum S, Rabinowitz A, Spencer-Dene B, Gulati S, Bates PA, Stamp G, Pickering L, Gore M, Nicol DL, Hazell S, Futreal PA, Stewart A, Swanton C (2014) Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet 46(3):225\u2013233. doi:\n                        10.1038\/ng.2891","journal-title":"Nat Genet"},{"issue":"6190","key":"4113_CR2","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL, Louis DN, Rozenblatt-Rosen O, Suva ML, Regev A, Bernstein BE (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344(6190):1396\u20131401. doi:\n                        10.1126\/science.1254257","journal-title":"Science"},{"issue":"14","key":"4113_CR3","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1093\/nar\/gkp457","volume":"37","author":"KE Varley","year":"2009","unstructured":"Varley KE, Mutch DG, Edmonston TB, Goodfellow PJ, Mitra RD (2009) Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing. Nucl Acids Res 37(14):4603\u20134612. doi:\n                        10.1093\/nar\/gkp457","journal-title":"Nucl Acids Res"},{"issue":"3","key":"4113_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/bcr3658","volume":"16","author":"LG Martelotto","year":"2014","unstructured":"Martelotto LG, Ng CK, Piscuoglio S, Weigelt B, Reis-Filho JS (2014) Breast cancer intra-tumor heterogeneity. Breast Cancer Res 16(3):210. doi:\n                        10.1186\/bcr3658","journal-title":"Breast Cancer Res"},{"issue":"5","key":"4113_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. doi:\n                        10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"7467","key":"4113_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell RA, McGranahan N, Bartek J, Swanton C (2013) The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501(7467):338\u2013345. doi:\n                        10.1038\/nature12625","journal-title":"Nature"},{"issue":"5","key":"4113_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrc3261","volume":"12","author":"A Marusyk","year":"2012","unstructured":"Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12(5):323\u2013334. doi:\n                        10.1038\/nrc3261","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"4113_CR8","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1073\/pnas.1114033109","volume":"109","author":"NJ Szerlip","year":"2012","unstructured":"Szerlip NJ, Pedraza A, Chakravarty D, Azim M, McGuire J, Fang Y, Ozawa T, Holland EC, Huse JT, Jhanwar S, Leversha MA, Mikkelsen T, Brennan CW (2012) Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc Natl Acad Sci USA 109(8):3041\u20133046. doi:\n                        10.1073\/pnas.1114033109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5827","key":"4113_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1126\/science.1141478","volume":"316","author":"JA Engelman","year":"2007","unstructured":"Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen J, Kosaka T, Holmes AJ, Rogers AM, Cappuzzo F, Mok T, Lee C, Johnson BE, Cantley LC, Janne PA (2007) MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 316(5827):1039\u20131043. doi:\n                        10.1126\/science.1141478","journal-title":"Science"},{"issue":"2","key":"4113_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1182\/blood-2002-06-1756","volume":"102","author":"WK Hofmann","year":"2003","unstructured":"Hofmann WK, Komor M, Wassmann B, Jones LC, Gschaidmeier H, Hoelzer D, Koeffler HP, Ottmann OG (2003) Presence of the BCR-ABL mutation Glu255Lys prior to STI571 (imatinib) treatment in patients with Ph+ acute lymphoblastic leukemia. Blood 102(2):659\u2013661. doi:\n                        10.1182\/blood-2002-06-1756","journal-title":"Blood"},{"key":"4113_CR11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7067","author":"LG Morris","year":"2016","unstructured":"Morris LG, Riaz N, Desrichard A, Senbabaoglu Y, Hakimi AA, Makarov V, Reis-Filho JS, Chan TA (2016) Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival. Oncotarget. doi:\n                        10.18632\/oncotarget.7067","journal-title":"Oncotarget"},{"issue":"1","key":"4113_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nm.3984","volume":"22","author":"N Andor","year":"2016","unstructured":"Andor N, Graham TA, Jansen M, Xia LC, Aktipis CA, Petritsch C, Ji HP, Maley CC (2016) Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nat Med 22(1):105\u2013113. doi:\n                        10.1038\/nm.3984","journal-title":"Nat Med"},{"issue":"2","key":"4113_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1172\/JCI40724","volume":"120","author":"SY Park","year":"2010","unstructured":"Park SY, Gonen M, Kim HJ, Michor F, Polyak K (2010) Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Investig 120(2):636\u2013644. doi:\n                        10.1172\/JCI40724","journal-title":"J Clin Investig"},{"issue":"4","key":"4113_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ng1768","volume":"38","author":"CC Maley","year":"2006","unstructured":"Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, Paulson TG, Blount PL, Risques RA, Rabinovitch PS, Reid BJ (2006) Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38(4):468\u2013473. doi:\n                        10.1038\/ng1768","journal-title":"Nat Genet"},{"issue":"2","key":"4113_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1172\/JCI42088","volume":"120","author":"LM Merlo","year":"2010","unstructured":"Merlo LM, Maley CC (2010) The role of genetic diversity in cancer. J Clin Investig 120(2):401\u2013403. doi:\n                        10.1172\/JCI42088","journal-title":"J Clin Investig"},{"issue":"6206","key":"4113_CR16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1126\/science.1253462","volume":"346","author":"EC Bruin de","year":"2014","unstructured":"de Bruin EC, McGranahan N, Mitter R, Salm M, Wedge DC, Yates L, Jamal-Hanjani M, Shafi S, Murugaesu N, Rowan AJ, Gronroos E, Muhammad MA, Horswell S, Gerlinger M, Varela I, Jones D, Marshall J, Voet T, Van Loo P, Rassl DM, Rintoul RC, Janes SM, Lee SM, Forster M, Ahmad T, Lawrence D, Falzon M, Capitanio A, Harkins TT, Lee CC, Tom W, Teefe E, Chen SC, Begum S, Rabinowitz A, Phillimore B, Spencer-Dene B, Stamp G, Szallasi Z, Matthews N, Stewart A, Campbell P, Swanton C (2014) Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346(6206):251\u2013256. doi:\n                        10.1126\/science.1253462","journal-title":"Science"},{"issue":"5","key":"4113_CR17","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ajpath.2012.07.012","volume":"181","author":"K Heselmeyer-Haddad","year":"2012","unstructured":"Heselmeyer-Haddad K, Berroa Garcia LY, Bradley A, Ortiz-Melendez C, Lee WJ, Christensen R, Prindiville SA, Calzone KA, Soballe PW, Hu Y, Chowdhury SA, Schwartz R, Schaffer AA, Ried T (2012) Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression. Am J Pathol 181(5):1807\u20131822. doi:\n                        10.1016\/j.ajpath.2012.07.012","journal-title":"Am J Pathol"},{"issue":"1","key":"4113_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/bioinformatics\/btt622","volume":"30","author":"N Andor","year":"2014","unstructured":"Andor N, Harness JV, Muller S, Mewes HW, Petritsch C (2014) EXPANDS: expanding ploidy and allele frequency on nested subpopulations. Bioinformatics 30(1):50\u201360. doi:\n                        10.1093\/bioinformatics\/btt622","journal-title":"Bioinformatics"},{"issue":"3","key":"4113_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.oraloncology.2012.09.007","volume":"49","author":"EA Mroz","year":"2013","unstructured":"Mroz EA, Rocco JW (2013) MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma. Oral Oncol 49(3):211\u2013215. doi:\n                        10.1016\/j.oraloncology.2012.09.007","journal-title":"Oral Oncol"},{"issue":"16","key":"4113_CR20","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1002\/cncr.28150","volume":"119","author":"EA Mroz","year":"2013","unstructured":"Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW (2013) High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer 119(16):3034\u20133042. doi:\n                        10.1002\/cncr.28150","journal-title":"Cancer"},{"issue":"2","key":"4113_CR21","doi-asserted-by":"publisher","first-page":"e1001786","DOI":"10.1371\/journal.pmed.1001786","volume":"12","author":"EA Mroz","year":"2015","unstructured":"Mroz EA, Tward AD, Hammon RJ, Ren Y, Rocco JW (2015) Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas. PLoS Med 12(2):e1001786. doi:\n                        10.1371\/journal.pmed.1001786","journal-title":"PLoS Med"},{"issue":"31","key":"4113_CR22","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1200\/JCO.2015.62.2126","volume":"33","author":"T Keenan","year":"2015","unstructured":"Keenan T, Moy B, Mroz EA, Ross K, Niemierko A, Rocco JW, Isakoff S, Ellisen LW, Bardia A (2015) Comparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrence. J Clin Oncol 33(31):3621\u20133627. doi:\n                        10.1200\/JCO.2015.62.2126","journal-title":"J Clin Oncol"},{"key":"4113_CR23","doi-asserted-by":"publisher","first-page":"11479","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, Pugh M, Jones L, Russell R, Sammut SJ, Tsui DW, Liu B, Dawson SJ, Abraham J, Northen H, Peden JF, Mukherjee A, Turashvili G, Green AR, McKinney S, Oloumi A, Shah S, Rosenfeld N, Murphy L, Bentley DR, Ellis IO, Purushotham A, Pinder SE, Borresen-Dale AL, Earl HM, Pharoah PD, Ross MT, Aparicio S, Caldas C (2016) The somatic mutation profiles of 2433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun 7:11479. doi:\n                        10.1038\/ncomms11479","journal-title":"Nat Commun"},{"key":"4113_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4137\/CIN.S9983","volume":"11","author":"X Chen","year":"2012","unstructured":"Chen X, Li J, Gray WH, Lehmann BD, Bauer JA, Shyr Y, Pietenpol JA (2012) TNBCtype: a subtyping tool for triple-negative breast cancer. Cancer Inform 11:147\u2013156. doi:\n                        10.4137\/CIN.S9983","journal-title":"Cancer Inform"},{"issue":"7","key":"4113_CR25","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, Pietenpol JA (2011) Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Investig 121(7):2750\u20132767. doi:\n                        10.1172\/JCI45014","journal-title":"J Clin Investig"},{"issue":"4","key":"4113_CR26","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G (2011) GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol 12(4):R41. doi:\n                        10.1186\/gb-2011-12-4-r41","journal-title":"Genome Biol"},{"issue":"3","key":"4113_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):267\u2013273. doi:\n                        10.1038\/ng1180","journal-title":"Nat Genet"},{"issue":"43","key":"4113_CR28","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545\u201315550. doi:\n                        10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7418","key":"4113_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61\u201370. doi:\n                        10.1038\/nature11412","journal-title":"Nature"},{"issue":"269","key":"4113_CR30","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1. doi:\n                        10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"issue":"3","key":"4113_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1470-2045(07)70074-8","volume":"8","author":"S Cleator","year":"2007","unstructured":"Cleator S, Heller W, Coombes RC (2007) Triple-negative breast cancer: therapeutic options. Lancet Oncol 8(3):235\u2013244. doi:\n                        10.1016\/S1470-2045(07)70074-8","journal-title":"Lancet Oncol"},{"issue":"5","key":"4113_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/sj.onc.1202410","volume":"18","author":"XY Yin","year":"1999","unstructured":"Yin XY, Grove L, Datta NS, Long MW, Prochownik EV (1999) C-myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene 18(5):1177\u20131184. doi:\n                        10.1038\/sj.onc.1202410","journal-title":"Oncogene"},{"issue":"4","key":"4113_CR33","doi-asserted-by":"publisher","first-page":"a014373","DOI":"10.1101\/cshperspect.a014373","volume":"4","author":"A Kuzyk","year":"2014","unstructured":"Kuzyk A, Mai S (2014) c-MYC-induced genomic instability. Cold Spring Harb Perspect Med 4(4):a014373. doi:\n                        10.1101\/cshperspect.a014373","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"38","key":"4113_CR34","doi-asserted-by":"publisher","first-page":"16387","DOI":"10.1073\/pnas.0901250106","volume":"106","author":"ER Andrechek","year":"2009","unstructured":"Andrechek ER, Cardiff RD, Chang JT, Gatza ML, Acharya CR, Potti A, Nevins JR (2009) Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential. Proc Natl Acad Sci USA 106(38):16387\u201316392. doi:\n                        10.1073\/pnas.0901250106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"4113_CR35","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/onc.2012.142","volume":"32","author":"DP Hollern","year":"2013","unstructured":"Hollern DP, Yuwanita I, Andrechek ER (2013) A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin-low human breast cancer. Oncogene 32(10):1296\u20131304. doi:\n                        10.1038\/onc.2012.142","journal-title":"Oncogene"},{"issue":"20","key":"4113_CR36","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/onc.2011.433","volume":"31","author":"JY Leung","year":"2012","unstructured":"Leung JY, Andrechek ER, Cardiff RD, Nevins JR (2012) Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence. Oncogene 31(20):2545\u20132554. doi:\n                        10.1038\/onc.2011.433","journal-title":"Oncogene"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4113-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4113-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4113-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T02:35:09Z","timestamp":1485916509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4113-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4113"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4113-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]}}}